Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study

Circulation

Volumn 109, Issue 24, 2004, Pages 2980-2985

  Veerkamp, Mario J ^a   De Graaf, Jacqueline ^a   Hendriks, Jan C M ^a   Demacker, Pierre N M ^a   Stalenhoef, Anton F H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apolipoproteins; Diagnosis; Follow up studies; Hyperlipoproteinemia

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; FAMILIAL DISEASE; FAMILIAL HYPERLIPEMIA; FAMILY STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; NOMOGRAMS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TRIGLYCERIDES;

EID: 3042558196     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000130646.93255.86     Document Type: Article

References (25)

1. Goldstein JL, Schrott HG, Hazzard WR, et al. Hyperlipidemia in coronary heart disease, II: genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52:1544-1568.
2. Porkka KV, Nuotio I, Pajukanta P, et al. Phenotype expression in familial combined hyperlipidemia. Atherosclerosis. 1997;133:245-253.
3. Gaddi A, Galetti C, Pauciullo P, et al. Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice: committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group. Nutr Metab Cardiovasc Dis. 1999;9:304-311.
4. Veerkamp MJ, de Graaf J, Bredie SJ, et al. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol. 2002;22:274-282.
5. McNeely MJ, Edwards KL, Marcovina SM, et al. Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study. Atherosclerosis. 2001;159:471-481.
6. Stalenhoef AF, Demacker PN, Lutterman JA, et al. Plasma lipoproteins, apolipoproteins, and triglyceride metabolism in familial hypertriglyceridemia. Arteriosclerosis. 1986;6:387-394.
7. Assmann G, Schulte H. Results and conclusions of the Prospective Cardiovascular Munster (PROCAM) study: lipid metabolism disorders and cardiovascular disease. MMV Medzin Verlag GmbH. 1993;19-68.
8. Demacker PN, Hijmans AG, Vos Janssen HE, et al. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin Chem. 1980;26:1775-1779.
9. Demacker PN, Veerkamp MJ, Bredie SJ, et al. Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia. Atherosclerosis. 2000;153:483-490.
10. Swinkels DW, Hak-Lemmers HL, Demacker PN. Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions. J Lipid Res. 1987;28:1233-1239.
11. de Graaf J, Swinkels DW, de Haan AF, et al. Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families. Am J Hum Genet. 1992;51:1295-1310.
12. Sniderman AD, Ribalta J, Castro Cabezas M. How should FCHL be defined and how should we think about its metabolic bases? Nutr Metab Cardiovasc Dis. 2001;11:259-273.
13. Bredie SJ, van Drongelen J, Kiemeney LA, et al. Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 1997;17:834-840.
14. Jarvik GP, Brunzell JD, Austin MA, et al. Genetic predictors of FCHL in four large pedigrees: influence of apoB level major locus predicted genotype and LDL subclass phenotype. Arterioscler Thromb. 1994;14:1687-1694.
15. Jarero JP, Aguilar-Salinas CA, Guillen-Pineda LE, et al. Lack of agreement between the plasma lipid-based criteria and apoprotein B for the diagnosis of familial combined hyperlipidemia in members of familial combined hyperlipidemia kindreds. Metabolism. 2002;51:218-224.
16. Ayyobi AF, McGladdery SH, Mc Neely MJ, et al. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2003;23:1289-1294.
17. Cortner JA, Coates PM, Liacouras CA, et al. Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management. J Pediatr. 1993;123:177-184.
18. Marcovina SM, Albers JJ, Kennedy H, et al. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B, IV: comparability of apolipoprotein B values by use of international reference material. Clin Chem. 1994;40:586-592.
19. Contois JH, McNamara JR, Lammi-Keefe CJ, et al. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem. 1996;42:515-523.
20. Lamarche B, Despres JP, Moorjani S, et al. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study). Am J Cardiol. 1995;75:1189-1195.
21. Bredie SJ, Kiemeney LA, de Haan AF, et al. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia. Am J Hum Genet. 1996;58:812-822.
22. Hokanson JE, Krauss RM, Albers JJ, et al. LDL physical and chemical properties in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 1995;15:452-459.
23. Vakkilainen J, Jauhiainen M, Ylitalo K, et al. LDL particle size in familial combined hyperlipidemia. Effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins. J Lipid Res. 2002;43:598-603.
24. Griffin BA, Freeman DJ, Tait GW, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 1994;106:241-253.
25. Ylitalo K, Syvanne M, Salonen R, et al. Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia. Atherosclerosis. 2002;162:171-178.